Jose A Seoane

17PUBLICATIONS
109CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 21, 2026
Epigenetic fingerprints link early-onset colon and rectal cancer to pesticide exposure.

|Mar 11, 2026
Inactivation of CDKN2AARF Promotes p53-Independent Remodeling of the PDAC Tumor Microenvironment.

Sofia Ferreira, Brittany M Flowers, Won-Young Choi

|Dec 22, 2025
Molecular and Clinical Analyses of Gene Fusions Identify Therapeutic Targets in Paired Primary and Metastatic Breast Cancer from the AURORA Program (BIG 14-01).

Chiara Biagioni, Danai Fimereli, Alexandre Irrthum

|Aug 25, 2025
Epigenetic synthetic lethality as a cancer therapeutic strategy: synergy of experimental and computational approaches.

Maria Farina-Morillas, Laia Ollé-Monràs, Silvana Ce Maas

|May 01, 2024
Epigenetic Control of Cancer Cell Dormancy and Awakening in Endocrine Therapy Resistance.

Arnau Llinas-Bertran, Meritxell Bellet-Ezquerra, Jose A Seoane

|Jul 19, 2023
p53 governs an AT1 differentiation programme in lung cancer suppression.

Alyssa M Kaiser, Alberto Gatto, Kathryn J Hanson

Pageof 3

Frequent Collaborators

7 joint publications

Christina Curtis

3 joint publications

Michael C Bassik

3 joint publications

Monte M Winslow

2 joint publications

Arnau Llinas-Bertran